Vericel Corp. (VCEL)
36.01
-0.72
(-1.96%)
USD |
NASDAQ |
Dec 31, 16:00
36.00
0.00 (0.00%)
After-Hours: 20:00
Vericel Profit Margin (Quarterly): 7.52% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.14% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| Marker Therapeutics, Inc. | -162.1% |
| Veracyte, Inc. | 14.51% |
| Aldeyra Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.44% |
| Return on Assets | 3.06% |
| Return on Invested Capital | 3.31% |
| Gross Profit Margin (Quarterly) | 73.46% |
| Operating Margin (Quarterly) | 5.11% |
| Return on Net Operating Assets | 5.17% |